Phenotypic resistance of herpes simplex virus type 1 strains selected in vitro with antiviral compounds and combinations thereof

Antiviral Chemistry and Chemotherapy

Volumn 7, Issue 5, 1996, Pages 270-275

  Morfin, F ^a   Snoeck, R ^a   Andrei, G ^a   De Clercq, E ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Acyclovir; Brivudin; Drug resistance; Herpes simplex virus

Indexed keywords

2,6 DIAMINO 9 (2 PHOSPHONOMETHOXYETHYL)PURINE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACICLOVIR; ADEFOVIR; ANTIVIRUS AGENT; CIDOFOVIR; FOSCARNET; GANCICLOVIR; NUCLEOSIDE ANALOG; PHOSPHONOACETIC ACID; SORIVUDINE; ZIDOVUDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS STRAIN;

EID: 0029738030     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029600700507     Document Type: Article

References (19)

1. Andrei, G., Snoeck, R., Goubau, P., Desmyter, J., and De Clercq, E. (1992) Comparative activity of various compounds against clinical strains of herpes simplex virus. Eur J Clin Microbiol Infect Dis 11: 143-151.
2. Andrei, G., Snoeck, R., Reymen, D., Liesnard, C., Goubau, P., Desmyter, J., and De Clercq, E. (1995a) Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis 14: 318-328.
3. Andrei, G., Snoeck, R., and De Clercq, E. (1995b) Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds. Antimicrob Agents Chemother 39: 1632-1635.
4. Collins, P. (1988) Viral sensitivity following the introduction of acyclovir. Am J Med 85: 129-134.
5. Collins, P., and Darby, G. (1991) Laboratory studies of herpes simplex virus strains resistant to acyclovir. Rev Med Virol 1: 19-28.
6. Crumpacker, C.S., Schnipper, L.E., Marlowe, S.I., Kowalsky, P.N., Hershey, B.J., and Levin, M.J. (1982) Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. W Engl J Med 306: 343-346.
7. De Clercq, E. (1982) Comparative efficacy of antiherpes drugs in different cell lines. Antimicrob Agents Chemother 21: 661-663.
8. De Clercq, E. (1984) The antiviral spectrum of (E)-5-(2-bromovinyl)-2′-deoxyuridine. J Antimicrob Chemother 14 (Suppl. A): 85-95.
9. De Clercq, E., and Holy, A. (1991) Efficacy of (S)-1-[3-hydroxy-2- (phosphonylmethoxy)-propyl (cytosine dihydrate (HPMPC) in various models of herpes simplex virus infection in mice. Antimicrob Agents Chemother 35: 801-806.
10. Field, A.K., and Biron, K.K. (1994) 'The end of innocence' revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev 7: 1-13.
11. Gibbs, J.S., Chiou, H.C., Bastow, K.F., Cheng, Y.C., and Coen, D.M. (1988) Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc Natl Acad Sci USA 85: 6672-6676.
12. Jennings Wilber, B.A., and Docherty, J.J. (1994) Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2′-deoxyuridine. J Gen Virol 75: 1743-1747.
13. Lalezari, J.P., Drew, W.L., Glutzer, E., Miner, D., Safrin, S., Owen Jr, W.F., Davidson, J.M., Fisher, P E., and Jaffe, H.S. (1994) Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS. J Infect Dis 170: 570-572.
14. Larder, B.A., Kemp, S.D., and Darby, G. (1987) Related functional domains in virus DNA polymerases. EMBO J 6: 169-175.
15. Safrin, S., Crumpacker, C., Chatis, P , Davis, R., Hafner, R., Rush, J., Kessler, H.A., Landry, B., and Mills, J. (1991) A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 325: 551-555.
16. Snoeck, R., Andrei, G., De Clercq, E., Gerard, M., Clumeck, N., Tricot, G., and Sadzot-Delvaux, C. (1993) A new topical treatment for resistant herpes simplex infections. New Engl J Med 329: 968-969.
17. Snoeck, R., Andrei, G., Gérard, M., Silverman, A., Hedderman, A., Balzarini, J., Sadzot-Delvaux, C., Tncot, G., Clumeck, N., and De Clercq, E. (1994) Successful treatment of progressive mucocutaneous acyclovir- and foscarnet-resistant herpes simplex virus infection with (S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl)cytosine (HPMPC). Clin Infect Dis 18: 570-578.
18. Whitley, R.J., and Gnann, J.W. (1992) Acyclovir: a decade later. N Engl J Med 327: 782-789.
19. Youle, M.M., Hawkins, D.A., Collins, P., Shanson, D.C., Evans, R., Oliver, N., and Lawrence, A. (1988) Acyclovir-resistant herpes in AIDS treated with foscarnet. Lancet ii: 341-342.